PCH
RVMD icon

Polar Capital Holdings’s Revolution Medicines RVMD Stock Holding History

Polar Capital Holdings’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$129M Sell
690,316
-443,614
-39% -$64.8M 0.31% 70
2026
Q1 		$110M Sell
1,133,930
-879,861
-44% -$88.8M 0.39% 60
2025
Q4 		$160M Buy
2,013,791
+1,535,686
+321% +$101M 0.62% 42
2025
Q3 		$22.3M Sell
478,105
-273,550
-36% -$10.7M 0.11% 142
2025
Q2 		$27.7M Buy
751,655
+990
+0.1% +$38K 0.14% 122
2025
Q1 		$26.5M Hold
750,665
– – 0.16% 128
2024
Q4 		$32.8M Buy
+750,665
New +$37.9M 0.18% 124

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Polar Capital Holdings's RVMD Position: Q2 2026 in Review

Polar Capital Holdings reduced its Revolution Medicines (RVMD) stake by 39% in Q2 2026, selling an estimated $64.8M and leaving 690,316 shares worth $129M. The position accounts for 0.31% of the portfolio, ranked #70.

Polar Capital Holdings first reported a position in RVMD in Q4 2024 and has held it in 7 quarters since. The position peaked at $160M in Q4 2025. 692 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Polar Capital Holdings held 690,316 shares of Revolution Medicines worth $129M as of Q2 2026.
  • Polar Capital Holdings sold 443,614 Revolution Medicines shares in Q2 2026, an estimated $64.8M.
  • Revolution Medicines made up 0.31% of Polar Capital Holdings's portfolio in Q2 2026, its #70 holding.
  • Polar Capital Holdings first reported a position in Revolution Medicines in Q4 2024 and has held it in 7 quarters since.
  • Polar Capital Holdings's Revolution Medicines position peaked at $160M in Q4 2025.
  • 692 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Polar Capital Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.